Why the study?
Does EMD 57033 improve cardiovascular performance during exercise in pigs with infarction-induced chronic left ventricular dysfunction?
Does EMD 57033 improve cardiovascular performance during exercise in pigs with infarction-induced chronic left ventricular dysfunction?
The pure Ca2+ sensitizer EMD 57033 maintains its positive inotropic effects during exercise in a porcine model of chronic LV dysfunction, unlike the mixed agent pimobendan, suggesting potential utility for inotropic support in heart failure without increasing myocardial oxygen demand.
Answers are grounded in this paper and cite their sources.
Does not support clinical use of EMD 57033; leaves open whether pure Ca2+ sensitization improves exercise hemodynamics in human HF.
It is unknown how cardiac stimulation by Ca(2+) sensitization modulates the cardiovascular response to exercise when left ventricular (LV) function is chronically depressed following a myocardial infarction. We therefore investigated the effects of EMD 57033 at rest and during exercise and compared these to those of the mixed Ca(2+)-sensitizer/phosphodiesterase-III inhibitor pimobendan. 2. Pigs were chronically instrumented for measurement of cardiovascular performance. At the time of instrumentation, infarction was produced by coronary artery ligation (MI, n=12). Studies in MI were performed in the awake state, 2 - 3 weeks after infarction. 3. MI were characterized by a lower resting cardiac output (18%), stroke volume (30%) and LVdP/dt(max) (18%), and a doubling of LV end-diastolic pressure, compared to normal pigs (N, n=13). 4. In 11 resting MI, intravenous EMD 57033 (0.2 - 0.8 mg kg(-1) min(-1)) increased LVdP/dt(max) (57+/-5%) and stroke volume (26+/-6%) with no effect on heart rate, LV filling pressure, and myocardial O(2)-consumption, similar to N. 5. In MI, the effects of EMD 57033 (0.4 mg kg(-1) min(-1), IV) on stroke volume and LVdP/dt(max) were maintained during treadmill exercise up to 85% of maximal heart rate, while heart rate was lower compared to control exercise (all P<0.05). In contrast, the effects of EMD57033 gradually waned in N at increasing intensity of exercise. 6. Compared to N, the cardiostimulatory effects of pimobendan (20 microg kg(-1) min(-1), IV) were blunted in MI both at rest and during exercise compared to N. 7. In conclusion, the positive inotropic actions of the Ca(2+) sensitizer EMD 57033 are unmitigated in resting and exercising MI compared to N, while those of the mixed Ca(2+)-sensitizer/phosphodiesterase-III inhibitor pimobendan are blunted.
No takes yet. Share an insight, caveat, or question.
Duncker et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: